RNA Clinical Trials Solutions

1. Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies 10/19/2022

   Stay on top of changes in the ever-evolving world of cell and gene therapies and more. Our in-house subject matter experts comb through the data weekly to ensure we provide you with the most current and comprehensive information important to this market.

2. Clinical And Regulatory Strategy 11/7/2023

   Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.

3. Regulatory Strategy And Submission Support 12/2/2025

   This Regulatory Operations Team enables biotech and pharmaceutical companies to focus on innovation while ensuring a smooth, compliant path to market entry.

4. Clinical Operations And Project Management For Every Phase 12/21/2022

   Get streamlined and integrated clinical trial services delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development. 

5. Orphan And Rare Disease CRO Services 11/7/2023

   Rare disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge for accelerated recruitment.

6. The Future Of Reimbursement For Cell & Gene Therapies 7/27/2022

   Our team excels at understanding the ever-changing and complex healthcare market and helping clients solve issues. Learn about the payer challenges, potential reimbursements, and the competition to consider.  

7. Oncology CRO Services 6/27/2023

   Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.

8. Pharmacometric Services 6/27/2023

   Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.

9. Earn The Trust Of Biotechs And Emerging Pharma 12/10/2025

   Backed by a global team of more than 3,000 professionals across 34 office locations, we deliver scalable, high-quality clinical development solutions tailored to the needs of emerging and mid-sized biotech companies.

10. Site Management Organization 11/7/2023

    Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.